Figure 1From: Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphomaPositron emission tomography scans. (A) Before treatment with lenalidomide; (B) after 4 months of continuous lenalidomide treatment; and (C) after 15 months of continuous lenalidomide treatment.Back to article page